Skip to main content
. 2019 Mar 13;33(9):1431–1439. doi: 10.1097/QAD.0000000000002197

Table 2.

Specific amino acid residues in the predicted R5 and X4/R5X4 V3 regions.

Residues in V3a R5, n = 97 X4/R5X4, n = 28 P value
T12 12 (12.4%) 11 (39.3%) 0.0040
R13 31 (32.0%) 18 (64.3%) 0.0037
V21 15 (15.5%) 14 (50.0%) 0.0005
K33 22 (22.7%) 21 (75.0%) <0.0001
T12 + R13 6 (6.2%) 11 (39.3%) <0.0001
T12 + K33 6 (6.2%) 10 (35.7%) 0.0002
R13 + V21 6 (6.2%) 13 (46.4%) <0.0001
R13 + K33 17 (17.5%) 16 (57.1%) 0.0001
V21 + K33 3 (3.1%) 13 (46.4%) <0.0001
T12 + R13 + V21 1 (1.0%) 7 (25.0%) 0.0001
T12 + R13 + K33 5 (5.2%) 10 (35.7%) 0.0001
T12 + V21 + K33 2 (2.1%) 7 (25.0%) 0.0004
R13 + V21 + K33 2 (2.1%) 12 (42.9%) <0.0001
T12 + R13 + V21 + K33 1 (1.0%) 7 (25.0%) 0.0001

K, lycine; R, argenine; R5, CCR5 tropic virus; R5X4, CCR5 and CXCR4 dual-tropic virus; T, threomine; V, valine; X4, CXCR4 tropic virus.

aAmino acid residues were numbered according to the HXB2 V3 sequence.